Table 4.

Association of cognitive impairment at baseline with CCR2-180G/A (V/I), CCR5-59029-G/A, IL4-589C/T, MCP1-2518-A/G, MBL2-H/L, P/Q and X/Y, and CCL3L1 copy number at baseline.

	ODDS RATIO	95% CI lower	95% CI upper	P-value
CCR2-180-G/A(V/I)
GA vs. GG	0.94	0.51	1.72	0.84
AA vs. GG	0.74	0.37	1.45	0.38
GA+AA (either GA or AA) vs. GG	0.87	0.49	1.56	0.64
CCR5-59029-G/A
GA vs. GG	0.73	0.37	1.44	0.36
AA vs. GG	0.94	0.64	1.38	0.75
GA+AA (either GA or AA) vs. GG	0.78	0.42	1.45	0.44
IL4-589-C/T
CT vs. TT	1.18	0.65	2.15	0.59
CC vs. TT	1.22	0.61	2.41	0.57
CT+CC (either CT or CC) vs. TT	1.21	0.68	2.16	0.52
MCP1-2518-A/G
GA vs. GG	0.90	0.48	1.69	0.74
AA vs. GG	0.86	0.55	1.35	0.51
GA+AA (either GA or AA) vs. GG	0.86	0.47	1.57	0.62
MBL2_HL
HL vs. HH	1.33	0.70	2.54	0.39
LL vs. HH	1.43	0.96	2.13	0.08
HL+LL (either HL or LL) vs. HH	1.54	0.86	2.75	0.15
MBL2_PQ
PQ vs. PP	0.67	0.31	1.45	0.31
QQ vs. PP	2.23	0.71	6.98	0.17
PQ+QQ (PQ or QQ) vs. PP	0.83	0.40	1.69	0.60
MBL2-XY
XY vs. YY	1.23	0.65	2.32	0.52
XX vs. YY	no estimate possible
XY+XX (XY or XX) vs. YY	1.10	0.59	2.05	0.98
CCL3L1
<3 copies vs. ≥3 copies	1.35	0.76	2.42	0.31
1 copy vs. >4 copies	0.67	0.29	1.51	0.33
1 copy vs. >5 copies	0.60	0.22	1.63	0.31